ASML 3Q’26: 2030 Arrived Four Years Early
ASML reported €11.7 billion in 3Q 2026 sales, up 55%, and raised full-year guidance to €44–45 billion as AI-driven semiconductor demand strengthens.
ASML reported €11.7 billion in 3Q 2026 sales, up 55%, and raised full-year guidance to €44–45 billion as AI-driven semiconductor demand strengthens.
contrarian in me could not resist. Sold a few Jun27 17C against $SKHN the 2x daily short ETF for $SKHY https://t.co/S1eYAvyno5
I'm very tempted to short $MRNA and $BSP, but I've never made money shorting tickers that are popular on Twitter. https://t.co/pVH61V6HTm
September 2026 write-ups: 1) $THRM RMT transaction (sort of a spin) 2) $CTVA $VYLR spin-off 3) Guide to M&A situations 4) $DECK beaten down (busted GARP) 5) $RAVE transitioning from turnaround to growth story https://t.co/fKWlrWNy4S
Free Recaps of the best new stock ideas, delivered every morning.
TSMC reported excellent Q3 results, guided Q4 revenue growth higher and saw its shares slip despite strong AI-driven earnings momentum.
October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…
Nvidia’s Ian Buck says CUDA’s software ecosystem, GPU flexibility and annual Vera Rubin upgrades lower token costs as agentic AI pushes…
Ari Emanuel discusses AI’s impact on Hollywood, live events, social networks and the future of advertising.
RTX’s $289 billion backlog, including $119 billion in defense, supports growth from defense contracts and commercial aerospace aftermarket…
Tesla’s Q2 revenue rose 26%, but operating margin fell to 1.4% and free cash flow was negative $1.1 billion as valuation reached 215x…
ASML’s €11.7 billion quarter benefited from €3.3 billion in installed-base sales and operating leverage, while the MATCH Act threatens…
Applied Materials leads wafer-fab deposition and ranks third in etch, positioning it for tougher 3D chip manufacturing as investors weigh a…
First Tracks Biotherapeutics’ ANB033 posted stronger Phase 1b celiac efficacy than Teva’s IL-15 inhibitor, with $168 million funding…
Micron reported Q4 FY26 revenue of $54.2 billion, up 379%, and guided Q1 revenue to $61.5 billion.
Vicor, Rayonier, Accenture and nine other lesser-covered stocks make up Seeking Alpha’s Undercovered Dozen.
Ben Pouladian argues AMD’s Helios racks cannot match NVIDIA GPUs’ fungibility and financing appeal as agentic AI shifts the bottleneck to…
EQT remains tied to roughly $3 Henry Hub gas despite European prices near $23 per MMBtu, with US LNG export capacity limiting overseas…
Microsoft plans to rebuild Xbox after FY2026 through studio cuts, higher hardware prices, Game Pass growth, exclusive releases and the 2028…
Asia's elevator boom favors maintenance and modernization providers, with Otis deriving nearly 90% of operating profit from after-sales…
Portfolio returned 65.7% through September 28 versus the S&P 500’s 13.2%, while backing Tourmaline, EQT, Athabasca and SLB on gas demand…
FTAI Aviation’s engine-exchange model swaps CFM56 engines in days rather than 200-day overhauls, driving Aerospace Products adjusted EBITDA…
Meta’s Enterprise Platform creates a third-party compute outlet, reducing the cost of overbuilding AI infrastructure while adding…
Archer Aviation's Insitu, Wisk and SkyGrid acquisitions add military and drone revenue, cutting FAA-certification dependence and leaving…
Have a source we’re missing? Send your pick
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.
Anything we’re missing?
Send us a pick